Clinical Report: Evaluating the Prognostic Significance of a Combined Immune-Inflammatory Profile in Cervical Cancer Patients Post-Surgery

Overview

This study investigates the prognostic significance of an integrated immune-inflammatory phenotype in cervical cancer patients post-surgery. The findings suggest that combining stromal tumor-infiltrating lymphocytes (TILs) and the systemic immune-inflammation index (SII) can enhance recurrence-free survival (RFS) stratification.

Background

Cervical cancer remains a significant global health issue, with high incidence and mortality rates. Postoperative recurrence risk is heterogeneous, and traditional clinicopathological factors may not adequately reflect the immune microenvironment's role. Understanding the immune context may improve risk assessment and treatment strategies for cervical cancer patients.

Data Highlights

Key Findings

• An integrated immune-inflammatory phenotype was associated with postoperative recurrence risk.
• Kaplan-Meier analysis revealed significant RFS differences based on TIL and SII categories.
• FIGO IIIC disease, positive margin status, and poor integrated phenotype were linked to worse RFS.
• LASSO-Cox model demonstrated the highest C-index and best discrimination at 24 and 36 months.
• Immunohistochemical validation indicated favorable phenotype characteristics, including higher CD8+ cell density.

Clinical Implications

The integrated immune-inflammatory phenotype may serve as a practical tool for stratifying recurrence risk in cervical cancer patients post-surgery. Clinicians should consider incorporating immune context into prognostic assessments to enhance treatment decision-making.

Conclusion

The study underscores the importance of integrating immune-inflammatory profiles in evaluating postoperative outcomes in cervical cancer. This approach may lead to improved risk stratification and tailored treatment strategies.

Related Resources & Content

1. Journal of Gastrointestinal Surgery, 2017 -- Clinical Implications of Serum Inflammatory Biomarkers in Gastric Cancer Prognosis
2. Journal of Gastrointestinal Surgery, 2018 -- Evaluating the Prognostic Significance of Staging Systems and Inflammatory Markers in Surgical Candidates with Combined Hepatocellular Cholangiocarcinoma: A Retrospective Analysis
3. Soluble intercellular adhesion molecule-1 as a predictor of outcomes in colorectal cancer, 2018
4. Frontiers in Oncology, 2026 -- Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer
5. Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology - PubMed
6. Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis - PMC
7. Making sense of TILs: recommendations for morphological assessment of tumour‐infiltrating lymphocytes in gastro‐oesophageal carcinoma - University of Birmingham
8. Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology - PubMed
9. Systemic immune-inflammatory index for the prediction of the survival in patients with cervical cancer: A meta-analysis - PMC
10. Making sense of TILs: recommendations for morphological assessment of tumour‐infiltrating lymphocytes in gastro‐oesophageal carcinoma: A report on behalf of the International Immuno‐Oncology Biomarker Working Group - University of Birmingham